As the rally in stocks belonging to the pharmaceutical and healthcare sector seems to calm down, S&P BSE Healthcare index fell by around 3.17 per cent since the beginning of October 2020. On the contrary, Laurus Labs has outperformed, gaining by about 17.81 per cent for the same period of time.

Mutual funds are one of the most effective ways of holding a portfolio of various kinds of stocks. Read on to find out more about the ways to boost portfolio returns with mutual funds.

With this partnership, Dr Reddy’s Laboratories can identify and use some of BIRAC’s clinical trial centres for the vaccine, which are funded under National Biopharma Mission (NBM) at BIRAC.

On Thursday, the domestic benchmark indices closed in the red. The markets remained volatile during today’s trading session as Sensex closed down by 172.61 points or 0.43 per cent to settle at 39,749.85 levels while Nifty ended the session down by 58.80 points or 0.50 per cent to close at 11,670.80 levels.

Pharma major, Cipla Limited, informed the bourses on Thursday that it was commercialising antibody detection kits for COVID-19 in India under the technology transfer from Indian Council of Medical Research (ICMR) in partnership with Karwa Limited.

The market opened in red on October 29, 2020.

The market opened in red on October 29, 2020, overall volumes in futures & options currently stand at 3,99,16,061 contracts with a turnover of Rs. 29,01,390.28 crore.

The market opened in red on October 29, 2020, overall volumes in futures & options currently stand at 3,99,16,061 contracts with a turnover of Rs. 29,01,390.28 crore.

Hero MotoCorp announced its results for the second quarter of FY2021, reporting a 9.05 per cent rise in the consolidated net profit to Rs 953 crore for the September quarter on the back of robust sales, signalling a gradual revival from the negative impact of the global pandemic.

Titan Company Limited reported its Q2FY21 results on Wednesday. The main revenue contributor of the company is its jewellery segment. Hence, the streets always give heavy weightage for this segment’s performance. Its jewellery segment saw a reduction of 2.31 per cent in revenue from Rs 3,528 crore in Q2FY20 to Rs 3,446 crore this year. These numbers are excluding the bullion sales of Rs 391 crore.